Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Promore Pharma

Less than 1K followers
All
Press releases
ShowingAll content types

Regulatory press release14.01.2025 klo 18.38

PMD Device Solutions' Bankruptcy Application Granted

Promore Pharma
Regulatory press release22.12.2024 klo 17.03

PMD Device Solutions AB (publ) has Filed for Bankruptcy

Promore Pharma
Regulatory press release29.11.2024 klo 09.00

Q3 Interim report July - September 2024

Promore Pharma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release26.11.2024 klo 09.30

PMD Device Solutions Completes Sale of Coala Life Monitor to Inventor Magnus Sörlander

Promore Pharma
Regulatory press release20.11.2024 klo 14.12

PMD Device Solutions Announces Delay to Q3 2024 Quarterly Report

Promore Pharma
Regulatory press release05.11.2024 klo 17.37

PMDS announces last day of trading in BTA

Promore Pharma
Regulatory press release29.10.2024 klo 15.13

Bulletin from the extraordinary general meeting in PMD Device Solutions AB (publ)

Promore Pharma
Regulatory press release29.10.2024 klo 15.10

Bulletin from the extraordinary general meeting in PMD Device Solutions AB (publ)

Promore Pharma
Regulatory press release14.10.2024 klo 08.00

NOTICE OF EXTRAORDINARY GENERAL MEETING IN PMD DEVICE SOLUTIONS AB (PUBL)

Promore Pharma
Regulatory press release11.10.2024 klo 10.22

PMDS’ Largest Shareholder Requests EGM to Appoint New Non-Executive Directors Amid Management Changes

Promore Pharma
Regulatory press release07.10.2024 klo 18.01

PMD Device Solutions Restructures to Focus Resources on Global Sales Expansion

Promore Pharma
Regulatory press release26.09.2024 klo 14.34

NOTICE OF EXTRAORDINARY GENERAL MEETING IN PMD DEVICE SOLUTIONS AB (PUBL)

Promore Pharma
Press release17.09.2024 klo 14.39

PMD Device Solutions’ RespiraSense Technology Demonstrates Capability in Predicting 7-Day Mortality

Promore Pharma
Regulatory press release12.09.2024 klo 17.55

PMDS carries out a directed issue of shares to underwriter in the completed rights issue

Promore Pharma
Press release11.09.2024 klo 09.04

PMDS Secures New Contract in the Western United States, Accelerating Path to Profitability

Promore Pharma
Press release05.09.2024 klo 20.18

PMD Device Solutions Secures Significant Sales Contract, Setting the Stage for Significant Growth in the US

Promore Pharma
Regulatory press release04.09.2024 klo 22.44

PMDS announces outcome of rights issue

Promore Pharma
Press release27.08.2024 klo 11.34

Redeye: PMD Solutions - PMD is approaching a cash-positive run rate before 2025

Promore Pharma
Regulatory press release22.08.2024 klo 09.00

Q2 Interim report April-June 2024

Promore Pharma
Regulatory press release17.08.2024 klo 00.15

PMDS publishes information memorandum in connection with the forthcoming rights issue

Promore Pharma